| Agent Name |
Ammonium perfluorooctanoate |
|---|
| CAS Number |
3825-26-1 |
|---|
| Formula |
C8-H-F15-O2.H3-N |
|---|
| Major Category |
Other Classes |
|---|
| Synonyms |
Ammonium pentadecafluorooctanoate; Ammonium perfluorocaprilate; Ammonium perfluorocaprylate; Ammonium perfluorooctanoate; Pentadecafluoro-1-octanoic acid, ammonium salt; Perfluoroammonium octanoate; Perfluorooctanoic acid, ammonium salt; [ChemIDplus] |
|---|
| Category |
Halogenated Aliphatics |
|---|
| Description |
White powder; [ACGIH] |
|---|
| Sources/Uses |
Used to polymerize fluorinated monomers; [ACGIH] |
|---|
| Comments |
Acute pulmonary edema is observed in animals exposed to lethal concentrations. [ChemIDplus] Confirmed animal carcinogen; Increased blood organofluoride levels in rats receiving repeated doses percutaneously; Workers found to have higher organofluoride levels that controls in plant with air concentrations of 0.032-7.6 mg/m3; Causes liver damage in subchronic animal studies; [ACGIH] |
|---|
| Exposure Assessment |
|---|
| Skin Designation (ACGIH) |
Yes |
|---|
| TLV (ACGIH) |
0.01 mg/m3 |
|---|
| Vapor Pressure |
7 x 10 -05 mm Hg |
|---|
| Lethal Concentration |
LC50 (rats) = 980 mg/m3/4H |
|---|
| Explanatory Notes |
BP = sublimes above 125 deg C; [ACGIH] |
|---|
| Half Life |
Organofluoride compounds: 1-2 years; [ACGIH] |
|---|
| Adverse Effects |
|---|
| Hepatotoxin |
Hepatotoxin, Secondary |
|---|
| Links to Other NLM Databases |
|---|
